Comparative pharmacodynamics of eight calcium channel blocking agents in Japanese essential hypertensive patients

Biological and Pharmaceutical Bulletin

Volumn 19, Issue 3, 1996, Pages 430-437

  Shimada, Shuji ^a   Nakajima, Yukiko ^a   Yamamoto, Koujirou ^a   Sawada, Yasufumi ^a,b   Iga, Tatsuji ^a  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

antihypertensive effect; calcium antagonist; ion channel binding; pharmacodynamic model

Indexed keywords

BENIDIPINE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; EFONIDIPINE; MANIDIPINE; MEPIRODIPINE; NICARDIPINE; NILVADIPINE; NITRENDIPINE;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BINDING AFFINITY; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARTMENT MODEL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISSOCIATION CONSTANT; DOSE TIME EFFECT RELATION; DRUG BINDING; DRUG BLOOD LEVEL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION;

EID: 0029876997     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.19.430     Document Type: Article

References (40)

1. Fleckenstein A., Circ. Res., 52, Suppl., 3-16 (1983).
2. 1988 Joint National Committee, Arch, Intern. Med., 148, 1023-1038 (1988).
3. Kikuchi K., Kobayashi H., Nakao T., Kondo A., Mito T., Tsuzuki M., Iimura O., bujise Y., Hanawa K., Jpn. J Clin. Pharmacol. Ther., 13, 623-637 (1982).
4. Yokoyama M., Kaburagi T., The Clinical Report, 15, 75-83 (1981).
5. Noda H., Itoh M., Fujita T., Jpn. Pharmacol. Ther., 18, Suppl., 703-711 (1990).
6. Shibouta Y., Kitayoshi T., Kitoh G., Nishikawa K., Jpn. J. Pharmacol., 48, 463-472 (1988).
7. Nagaoka A., Kito G., Nagai Y., Jpn Pharmacol Ther , 18, 2523-2532 (1990).
8. WHO Technical Report Series, No. 628, WHO, Jeneva 1978.
9. Umeda T., Naomi S., Iwaoka D., Inoue J., Otmo M., Hamazaki S., Miura F., Sato T., Jpn. J. Clin. Pharmacol Ther., 17, 735-748 (1986).
10. Umeda T., Iwaoka D., Miura F., Naomi S., Ohno M., Sasaki M., Sato T., Inoue J., Hamazaki S., Jpn. J Clin Exp. Med., 66, 615-620 (1989).
11. Suzuki S., Takahira T., Mori M., J. Clin. Therap. Med., 6, 1089-1095 (1990).
12. Saruta T., Suzuki H., J. Med. Pharm. Sci., 28, 178-185 (1992).
13. Yokoyama S., Kaburagi T., Mori N., Sakata K., Yoshida H., Hoshino T., Jpn. J. Nephrol., 34, 199-205 (1992).
14. Ishii A., Toyama J., J. Cardiovasc. Pharmacol., 21, 191-196 (1993).
15. Yamada S., Kimura R., Harada Y , Nakayama K., J. Pharmacol. Exp. Ther., 252, 327-332 (1989).
16. Matsuo M., Koibuchi Y., Tomoi M , Ono T., Shibayama F., Ohtsuka M., Arzneim.-Forsch. Drug Res., 39, 576-579 (1989).
17. Yamashita T., Masuda Y., Sakai T., Tanaka S., Kasuya Y., Jpn J Pharmacol., 57, 337-348 (1991).
18. Yamaoka K., Tanigawara Y., Nakagawa T., Uno T., J. Pharmacobio-Dyn., 4, 879-885 (1981).
19. Yamaoka K., Nakagawa T., Uno T., J Pharmacokinet Biopharm., 6, 165-175 (1978).
20. Sheiner L. B., Stanski D. R., Vozeh S., Miller R. D., Ham J., Clin. Pharmacol Ther., 25, 358-371 (1979).
21. D'Hollander A. A., Delcroix C., J. Pharmacokinet. Biopharm., 9, 27-40 (1981).
22. D'Hollander A. A., Delcroix C., Duvaldestin P., Henzel D., Coussaert E., Desmonts J. M., Eur. J. Clin. Pharmacol., 24, 407-413 (1983).
23. Vozeh S., Uematsu T., Hauf G. F., Follath F., J. Pharmacokinet. Biopharm., 13, 203-212 (1985).
24. Yamaoka K., Nakagawa T., J Pharmacobio-Dyn , 6, 595-606 (1983).
25. Yoshinaga K., Iimura O., Abe K., Ishii T., Saruta T., Kaneko Y., Ito K., Masuyama Y., Kokuhu T., Arakawa N., Jpn. Pharmacol. Ther., 18, Suppl., 4, 721-729 (1990).
26. Kitajima K., Hayashi M., Suzuki H., Saruta T., Kidney and Dialysis, 29, 809-816 (1990).
27. Suzuki S., Morimoto I., The Clinical Report. 23, 5043-5054 (1989).
28. Yokoyama S , Mori N., Kaburagi T., Eguchi T., Jpn. Pharmacol. Ther., 20, 281-287 (1992).
29. Speeding M., Trends Pharmacol. Sci., 6, 109-114 (1985).
30. Nosaka C., Ishii A., The Clinical Report, 25, 3887-3893 (1991).
31. Jusko W. J., Clin. Pharmacol. Ther., 54, 112-113 (1993).
32. Kleinbloesem C, H., Brummelen P. V., Harten J. V., Danhof M., Breimer D. D., Clin Pharmacol. Ther., 37, 563-574 (1985).
33. Urien S., Albengres E., Comte A., Kiechel J. R., Tillement J. F., J. Cardiovasc. Pharmacol, 7, 891-898 (1985).
34. Niwa T., Tokuma Y , Noguchi H., Res Commun Chem. Pathol. Pharmacol., 55, 75-88 (1987).
35. Goa K. L., Sorkin E. M., Drugs, 33, 123-155 (1987).
36. Shinozaki U., Himori Y., Sano H., Xenobio. Metab. Dispos., 6, 945-953 (1991).
37. Rhodes D. G., Sarmiento J. G , Herbette L. G., Mol Pharmacol., 27, 612-623 (1985).
38. Herbette L. G., Vant Erve Y. M. H., Rhodes D. G., J. Mol. Cell Cardiol., 21, 187-201 (1989).
39. Herbette L. G., Chester D. W., Rhodes D. G., Biophys. J., 49, 91-94 (1986).
40. Chester D. W., Herbette L. G., Mason R. P., Joslyn A. F . Triggle D. J., Koppel D. E., Biophys. J., 52, 1021-1030 (1987).